201 - 250 of 9030 Results
Title
Year
-
RESTRICTEDTitle: The Endo-lysosomal System in Parkinson’s Disease: Expanding the HorizonJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 168140End Page: 168140Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140Best OA location URL: https://doi.org/10.1016/j.jmb.2023.168140Citation Count: 9
- Gene therapy to target ER stress in brain diseases2016RESTRICTEDTitle: Gene therapy to target ER stress in brain diseasesJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 561End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.04.064Citation Count: 31
-
RESTRICTEDTitle: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 5Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00284Citation Count: 0
-
RESTRICTEDTitle: Enduring questions in regenerative biology and the search for answersJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-023-05505-7Best OA location URL: https://www.nature.com/articles/s42003-023-05505-7.pdfCitation Count: 0
- Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort2021RESTRICTEDTitle: Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a CohortJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.634666Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.634666/pdfCitation Count: 3
- ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease2022RESTRICTEDTitle: ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.848215Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.848215/pdfCitation Count: 17
-
RESTRICTEDTitle: Active Learning in Psychiatry Education: Current Practices and Future PerspectivesJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2020.00211Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00211/pdfCitation Count: 19
-
RESTRICTEDTitle: Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experienceJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.653377Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.653377/pdfCitation Count: 19
-
RESTRICTEDTitle: Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 13Issue #: 3Start Page: 279End Page: 296Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230021Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230021?id=journal-of-parkinsons-disease%2Fjpd230021Citation Count: 3
-
RESTRICTEDTitle: Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson’s Disease: An Insight Into Role of Pharmacological InterventionsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.584513Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.584513/pdfCitation Count: 28
-
RESTRICTEDTitle: Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJournal Name: Frontiers in Bioengineering and BiotechnologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fbioe.2022.1035543Best OA location URL: https://www.frontiersin.org/articles/10.3389/fbioe.2022.1035543/pdfCitation Count: 7
-
RESTRICTEDTitle: Machine Learning Methods to Predict Acute Respiratory Failure and Acute Respiratory Distress SyndromeJournal Name: Frontiers in Big DataPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdata.2020.579774Best OA location URL: https://www.frontiersin.org/articles/10.3389/fdata.2020.579774/pdfCitation Count: 16
-
RESTRICTEDTitle: The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-AnalysisJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1807End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223215Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223215?id=journal-of-parkinsons-disease%2Fjpd223215Citation Count: 4
-
RESTRICTEDTitle: Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicineJournal Name: Frontiers in Molecular MedicinePublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmmed.2022.933383Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmmed.2022.933383/pdfCitation Count: 0
-
RESTRICTEDTitle: Annexins Bridging the Gap: Novel Roles in Membrane Contact Site FormationJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.797949Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2021.797949/pdfCitation Count: 10
-
RESTRICTEDTitle: Epidemiological Evidence for an Immune Component of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: s1Start Page: S29End Page: S43Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223180Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223180?id=journal-of-parkinsons-disease%2Fjpd223180Citation Count: 8
-
RESTRICTEDTitle: A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1841End Page: 1861Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223262Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223262?id=journal-of-parkinsons-disease%2Fjpd223262Citation Count: 8
-
RESTRICTEDTitle: Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic DisorderJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 8Start Page: 2353End Page: 2367Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223380Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223380?id=journal-of-parkinsons-disease%2Fjpd223380Citation Count: 6
-
RESTRICTEDTitle: Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-UpJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 7Start Page: 2071End Page: 2083Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223295Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223295?id=journal-of-parkinsons-disease%2Fjpd223295Citation Count: 9
-
RESTRICTEDTitle: A Guide for the Differential Diagnosis of Multiple System Atrophy in Clinical PracticeJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 7Start Page: 2015End Page: 2027Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223392Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223392?id=journal-of-parkinsons-disease%2Fjpd223392Citation Count: 5
-
RESTRICTEDTitle: A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine SystemJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 8Start Page: 2307End Page: 2320Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223452Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223452?id=journal-of-parkinsons-disease%2Fjpd223452Citation Count: 5
- Infusion Therapies for Parkinson’s Disease2020RESTRICTEDTitle: Infusion Therapies for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-020-01062-2Citation Count: 12
- The Role of Genetic Testing for Parkinson’s Disease2021RESTRICTEDTitle: The Role of Genetic Testing for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01100-7Citation Count: 14
- Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views2021RESTRICTEDTitle: Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding ViewsJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01140-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020458Citation Count: 13
-
RESTRICTEDTitle: Moving the Dial Toward Equity in Parkinson’s Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial ParticipationJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 475End Page: 483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-022-01212-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578442Citation Count: 12
-
RESTRICTEDTitle: Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic HypotensionJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11910-021-01104-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01104-3.pdfCitation Count: 6
-
RESTRICTEDTitle: Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained LoopJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 427End Page: 440Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11910-022-01207-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-022-01207-5.pdfCitation Count: 23
-
RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7
-
RESTRICTEDTitle: Digital Technology in Movement Disorders: Updates, Applications, and ChallengesJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01101-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01101-6.pdfCitation Count: 30
- Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease2020RESTRICTEDTitle: Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 6Start Page: 559End Page: 577Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00727-3Citation Count: 6
-
RESTRICTEDTitle: 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical RecommendationsJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 2Start Page: 137End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-020-00782-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-020-00782-w.pdfCitation Count: 17
- Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders2021RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysisJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1269End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-022-00963-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-022-00963-9.pdfCitation Count: 14
- Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease2022RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
-
RESTRICTEDTitle: The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and SuitabilityJournal Name: Drugs & AgingPublisher: Springer Science and Business Media LLCVol: 38Issue #: 5Start Page: 355End Page: 373Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40266-021-00853-7Best OA location URL: https://discovery.ucl.ac.uk/10124963/5/Foltynie_Incretin-based_Therapies_Review_CG_24.02.21CA.pdfCitation Count: 6
- Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid2020RESTRICTEDTitle: Neutrophil activation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluidJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 62Issue #:Start Page: 101130End Page: 101130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2020.101130Citation Count: 26
-
RESTRICTEDTitle: What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 79Issue #:Start Page: 101648End Page: 101648Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2022.101648Best OA location URL: https://doi.org/10.1016/j.arr.2022.101648Citation Count: 11
- Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis2022RESTRICTEDTitle: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axisJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 106113End Page: 106113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113Citation Count: 8
- Mechanisms of NLRP3 activation and pathology during neurodegeneration2022RESTRICTEDTitle: Mechanisms of NLRP3 activation and pathology during neurodegenerationJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 151Issue #:Start Page: 106273End Page: 106273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273Citation Count: 10
- Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivo2023RESTRICTEDTitle: Strategies for quantifying the enzymatic activities of glycoside hydrolases within cells and in vivoJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 102403End Page: 102403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2023.102403Citation Count: 0
-
RESTRICTEDTitle: Orthostatic Hypotension in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 53End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.002Best OA location URL: https://europepmc.org/articles/pmc7029426?pdf=renderCitation Count: 48
- Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat2020RESTRICTEDTitle: Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the ratJournal Name: Canadian Journal of Physiology and PharmacologyPublisher: Canadian Science PublishingVol: 98Issue #: 7Start Page: 431End Page: 440Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1139/cjpp-2019-0551Citation Count: 7
- Initiation of pharmacological therapy in Parkinson's disease: when, why, and how2020RESTRICTEDTitle: Initiation of pharmacological therapy in Parkinson's disease: when, why, and howJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 452End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30036-3Citation Count: 121
-
RESTRICTEDTitle: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 951End Page: 962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8Best OA location URL: http://manuscript.elsevier.com/S1474442220303148/pdf/S1474442220303148.pdfCitation Count: 283
-
RESTRICTEDTitle: Progress towards therapies for disease modification in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2Best OA location URL: https://discovery.ucl.ac.uk/10130306/1/Foltynie_Disease%20Modifying%20reviewVersion4_ML2_CLEAN.pdfCitation Count: 157
-
RESTRICTEDTitle: A biological classification of Huntington's disease: the Integrated Staging SystemJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 7Start Page: 632End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-xBest OA location URL: https://discovery.ucl.ac.uk/10151755/1/21.08.12%20HD-ISS%20Manuscript%20final%20submitted.pdfCitation Count: 86
-
RESTRICTEDTitle: Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 124End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.027Best OA location URL: http://www.prd-journal.com/article/S1353802021001206/pdfCitation Count: 25